CRP and rheumatoid arthritis: In patients with RA without TNFi, 63.3% of whom were on pregnancy-compatible disease-modifying drugs, both the DAS28-CRP scores as well as CRP levels showed low disease activity during the course of pregnancy, and only 26.7% of patients required initiation of therapy.